HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kei Suzuki Selected Research

Ecthyma

5/2014[A patient with acute Philadelphia-chromosome-positive mixed phenotype leukemia developing ecthyma gangrenosum while undergoing combined imatinib mesylate chemotherapy].
11/2009[A patient with acute Philadelphia-chromosome-positive mixed phenotype leukemia developing ecthyma gangrenosum while undergoing combined imatinib mesylate chemotherapy].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kei Suzuki Research Topics

Disease

18Neoplasms (Cancer)
02/2024 - 12/2009
12Infections
09/2023 - 01/2008
12Disseminated Intravascular Coagulation
02/2022 - 02/2016
8Fever (Fevers)
10/2023 - 08/2008
8Hemorrhage
12/2022 - 02/2009
6Thrombosis (Thrombus)
12/2021 - 11/2016
5Hemophilia A (Haemophilia)
09/2023 - 07/2018
5Septic Shock (Toxic Shock Syndrome)
11/2022 - 11/2009
5Leukemia
01/2019 - 11/2009
4Esophageal Neoplasms (Esophageal Cancer)
10/2023 - 01/2019
4Edema (Dropsy)
02/2023 - 11/2009
4Communicable Diseases (Infectious Diseases)
02/2021 - 02/2016
4Thrombotic Microangiopathies
01/2021 - 01/2018
4Shock
02/2017 - 02/2009
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2014 - 05/2007
4Breakthrough Infections
11/2014 - 08/2008
3Bacteremia
10/2023 - 01/2016
3Sepsis (Septicemia)
01/2023 - 02/2017
3Adenocarcinoma of Lung
01/2022 - 02/2013
3Tachycardia (Tachyarrhythmias)
03/2021 - 12/2016
3Coma (Comas)
03/2021 - 12/2020
3Hematologic Diseases (Blood Diseases)
02/2021 - 08/2010
3Hematologic Neoplasms (Hematological Malignancy)
01/2020 - 08/2008
3Thrombocytopenia (Thrombopenia)
01/2018 - 04/2010
3Neutropenia
11/2014 - 02/2009
3Pneumonia (Pneumonitis)
11/2014 - 02/2009
3Malignant Mesothelioma
02/2012 - 01/2011
2Pulmonary Embolism
10/2023 - 11/2022
2Thrombophilia
09/2023 - 12/2020
2Pneumothorax
09/2023 - 11/2022
2Out-of-Hospital Cardiac Arrest
03/2021 - 12/2020
2Critical Illness (Critically Ill)
03/2021 - 01/2016
2Multiple Organ Failure (MODS)
02/2021 - 01/2016
2Adenocarcinoma
11/2020 - 08/2020
2Heart Arrest (Cardiac Arrest)
01/2020 - 06/2019
2Pleural Effusion (Pleural Effusions)
10/2019 - 01/2013
2Lung Neoplasms (Lung Cancer)
08/2019 - 04/2016
2Hemolytic-Uremic Syndrome
06/2019 - 01/2018
2Thrombotic Thrombocytopenic Purpura
06/2019 - 01/2018
2Tachypnea
12/2018 - 12/2016
2Acidosis
02/2017 - 04/2014
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2016 - 08/2011
2Wounds and Injuries (Trauma)
01/2016 - 07/2014
2Hemorrhagic Shock
11/2014 - 02/2009
2Ulcer
11/2014 - 02/2009
2Interstitial Lung Diseases (Interstitial Lung Disease)
11/2014 - 02/2009
2Zygomycosis (Phycomycosis)
11/2014 - 02/2009
2Drug-Related Side Effects and Adverse Reactions
05/2014 - 11/2009
2Ecthyma
05/2014 - 11/2009
2Erythema
05/2014 - 11/2009
2Philadelphia Chromosome
05/2014 - 11/2009
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2014 - 11/2009
2Trichosporonosis
05/2010 - 08/2008
2Fatigue
08/2008 - 01/2008
1Rhabdomyosarcoma
10/2023
1Osteoporosis
08/2023

Drug/Important Bio-Agent (IBA)

14Dacarbazine (DIC)FDA LinkGeneric
01/2023 - 02/2016
8Anti-Bacterial Agents (Antibiotics)IBA
11/2022 - 02/2009
6AntithrombinsIBA
01/2023 - 02/2016
5ThrombomodulinIBA
01/2023 - 02/2016
4Fibrinogen (Factor I)FDA Link
01/2023 - 02/2016
4Proteins (Proteins, Gene)FDA Link
09/2020 - 05/2011
4Micafungin (FK463)FDA Link
11/2014 - 08/2008
3AntibodiesIBA
02/2024 - 07/2018
3Biomarkers (Surrogate Marker)IBA
02/2024 - 01/2011
3Factor VIII (Coagulation Factor VIII)IBA
09/2023 - 07/2018
3ThrombinFDA Link
09/2023 - 02/2016
3Rituximab (Mabthera)FDA Link
01/2021 - 04/2008
3EchinocandinsIBA
11/2014 - 08/2008
3Prednisolone (Predate)FDA LinkGeneric
11/2014 - 02/2009
3SteroidsIBA
11/2014 - 02/2009
2emicizumabIBA
09/2023 - 10/2022
2Heparin (Liquaemin)FDA LinkGeneric
01/2022 - 12/2020
2BilirubinIBA
01/2020 - 12/2018
2AnticoagulantsIBA
01/2019 - 01/2016
2FibrinIBA
07/2018 - 11/2016
2CatecholaminesIBA
02/2017 - 12/2016
2Meropenem (Merrem)FDA LinkGeneric
11/2014 - 02/2009
2Voriconazole (Vfend)FDA LinkGeneric
11/2014 - 02/2009
2AntigensIBA
11/2014 - 02/2009
2Antifungal AgentsIBA
11/2014 - 02/2009
2Imatinib Mesylate (Gleevec)FDA Link
05/2014 - 11/2009
2MethylprednisoloneFDA LinkGeneric
08/2008 - 05/2007
1Volatile Organic CompoundsIBA
02/2024

Therapy/Procedure

29Therapeutics
09/2023 - 08/2008
9Drug Therapy (Chemotherapy)
10/2023 - 01/2008
5Radiotherapy
01/2023 - 07/2014
5Catheters
12/2020 - 01/2008
4Extracorporeal Membrane Oxygenation
08/2023 - 12/2018
3Induced Hypothermia
03/2021 - 03/2020
3Induction Chemotherapy
08/2019 - 01/2016
2Neoadjuvant Therapy
10/2023 - 11/2020
2Chest Tubes (Chest Tube)
09/2023 - 11/2022
2Mechanical Ventilators (Ventilator)
11/2022 - 01/2016
2Chemoradiotherapy
11/2022 - 06/2019
2Esophagectomy
08/2020 - 06/2019
2Immunotherapy
03/2020 - 12/2011
1Operative Surgical Procedures
12/2023
1Central Venous Catheters
10/2023
1Pneumonectomy (Lung Volume Reduction)
09/2023